Download PDF
Thromb Haemost 2003; 90(01): 157
DOI: 10.1055/s-0037-1613613
Letters to the Editor
Schattauer GmbH

Elevated erythrocyte aggregation as a predisposing factor to aspirin resistance

Halûk Demiroglu
Further Information

Publication History

Received 20 February 2003

Accepted 11 March 2003

Publication Date:
07 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 McKee SA, Sane DC, Deliargyris EN. Aspirin resistance in cardiovascular disease: a review of prevalenve, mechanisms, and clinical significance. Thromb Haemost 2002; 88: 711-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Resch KL, Ernst E, Matrai A. et al. Can rheologic variables be of prognostic relevance in arteriosclerotic disease?. Angiology 1991; 41: 963-70.
    PubMedGoogle Scholar
  • 3 Stoltz JF, Donner M. Hemorheology: importance of erythrocyte aggregation. Clin Hemorheol 1987; 7: 15-23.
    PubMedGoogle Scholar
  • 4 Demiroglu H. The importance of erythrocyte aggregation in blood rheology: considerations on the pathophysiology of thrombotic disorders. Blood 1997; 89: 4236
    PubMedGoogle Scholar
  • 5 Demiroglu H, Barista I, Dundar S. The effects of age and menopause on erythrocyte aggregation. Thromb Haemost 1997; 77: 404
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Demiroglu H, Yalcin S, Buyukasik Y. et al. Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behçet’s disease: a prospective study. Ann Rheum Dis 1998; 57: 694-6.
    CrossrefPubMedGoogle Scholar
  • 7 Demiroglu H, Gurlek A, Barista I. Enhanced erythrocyte aggregation in type 2 diabetes with late complications. Exp Clin Endocrinol Diabetes 1999; 107: 35-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Demiroglu H, Barista I, Dundar S. Erythrocyte aggregability in patients with coronary heart disease. Clin Hemorheol 1996; 16: 313-7.
    PubMedGoogle Scholar
  • 9 Hayakawa M, Kuzuya F. Effects of ticlopidine on erythrocyte aggregation in thrombotic disorders. Angiology 1991; 42: 747-53.
    CrossrefPubMedGoogle Scholar
  • 10 Mehta SR, Yusuf S. The Clopidogrel in Unstable angina to prevent Recurrent events (CURE) Study Investigators. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000; 24: 2033-41.
    PubMedGoogle Scholar